Protracted viral shedding and viral load are associated with ICU mortality in Covid-19 patients with acute respiratory failure.
Acute respiratory distress syndrome
Acute respiratory failure
COVID-19
Polymerase chain reaction
SARS-COV-2
Viral load
Viral shedding
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
10 Dec 2020
10 Dec 2020
Historique:
received:
03
10
2020
accepted:
25
11
2020
entrez:
10
12
2020
pubmed:
11
12
2020
medline:
11
12
2020
Statut:
epublish
Résumé
Protracted viral shedding is common in hospitalized patients with COVID-19 pneumonia, and up to 40% display signs of pulmonary fibrosis on computed tomography (CT) after hospital discharge. We hypothesized that COVID-19 patients with acute respiratory failure (ARF) who die in intensive care units (ICU) have a lower viral clearance in the respiratory tract than ICU patients discharged alive, and that protracted viral shedding in respiratory samples is associated with patterns of fibroproliferation on lung CT. We, therefore, conducted a retrospective observational study, in 2 ICU of Lyon university hospital. 129 patients were included in the study, of whom 44 (34%) died in ICU. 432 RT-PCR for SARS-CoV-2 were performed and 137 CT scans were analyzed. Viral load was significantly higher in patients deceased as compared to patients alive at ICU discharge (p < 0.001), after adjustment for the site of viral sampling and RT-PCR technique. The median time to SARS-CoV-2 negativation on RT-PCR was 19 days [CI Viral load in respiratory samples is significantly lower and viral shedding significantly shorter in ICU survivors of COVID-19 associated acute respiratory failure. Protracted viral shedding is unrelated to occurrence of fibrosis on lung CT.
Sections du résumé
BACKGROUND
BACKGROUND
Protracted viral shedding is common in hospitalized patients with COVID-19 pneumonia, and up to 40% display signs of pulmonary fibrosis on computed tomography (CT) after hospital discharge. We hypothesized that COVID-19 patients with acute respiratory failure (ARF) who die in intensive care units (ICU) have a lower viral clearance in the respiratory tract than ICU patients discharged alive, and that protracted viral shedding in respiratory samples is associated with patterns of fibroproliferation on lung CT. We, therefore, conducted a retrospective observational study, in 2 ICU of Lyon university hospital.
RESULTS
RESULTS
129 patients were included in the study, of whom 44 (34%) died in ICU. 432 RT-PCR for SARS-CoV-2 were performed and 137 CT scans were analyzed. Viral load was significantly higher in patients deceased as compared to patients alive at ICU discharge (p < 0.001), after adjustment for the site of viral sampling and RT-PCR technique. The median time to SARS-CoV-2 negativation on RT-PCR was 19 days [CI
CONCLUSIONS
CONCLUSIONS
Viral load in respiratory samples is significantly lower and viral shedding significantly shorter in ICU survivors of COVID-19 associated acute respiratory failure. Protracted viral shedding is unrelated to occurrence of fibrosis on lung CT.
Identifiants
pubmed: 33301059
doi: 10.1186/s13613-020-00783-4
pii: 10.1186/s13613-020-00783-4
pmc: PMC7725883
doi:
Types de publication
Journal Article
Langues
eng
Pagination
167Références
Transbound Emerg Dis. 2020 Nov;67(6):2971-2982
pubmed: 32531138
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Clin Infect Dis. 2020 Jun 30;:
pubmed: 32603425
J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2
pubmed: 32360285
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1435-1438
pubmed: 32293905
J Infect. 2020 Jul;81(1):147-178
pubmed: 32209381
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Eur J Radiol. 2020 Jun;127:109009
pubmed: 32325282
AJR Am J Roentgenol. 2020 May;214(5):1072-1077
pubmed: 32125873
Crit Care Med. 2020 Sep;48(9):e799-e804
pubmed: 32452888
Clin Infect Dis. 2020 May 22;:
pubmed: 32442256
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Clin Infect Dis. 2020 Nov 19;71(16):2249-2251
pubmed: 32306036
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Invest Radiol. 2020 Jun;55(6):327-331
pubmed: 32118615
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Chest. 2014 Nov;146(5):1196-1204
pubmed: 24722949
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
AJR Am J Roentgenol. 2020 Jun;214(6):1287-1294
pubmed: 32134681
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
J Xray Sci Technol. 2020;28(3):383-389
pubmed: 32474479
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379
pubmed: 32242738
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
CMAJ. 2020 Jun 29;192(26):E694-E701
pubmed: 32461326